ZA931777B - Substituted pyrrolidine derivatives as HIV protease inhibitors. - Google Patents

Substituted pyrrolidine derivatives as HIV protease inhibitors.

Info

Publication number
ZA931777B
ZA931777B ZA931777A ZA931777A ZA931777B ZA 931777 B ZA931777 B ZA 931777B ZA 931777 A ZA931777 A ZA 931777A ZA 931777 A ZA931777 A ZA 931777A ZA 931777 B ZA931777 B ZA 931777B
Authority
ZA
South Africa
Prior art keywords
hiv
protease inhibitors
hiv protease
pyrrolidine derivatives
compounds
Prior art date
Application number
ZA931777A
Other languages
English (en)
Inventor
Vida Gorys
Francois Soucy
Christiane Yoakim
Pierre Louis Beaulieu
Original Assignee
Bio Mega Boehringer Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mega Boehringer Ingelheim filed Critical Bio Mega Boehringer Ingelheim
Publication of ZA931777B publication Critical patent/ZA931777B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA931777A 1992-03-13 1993-02-12 Substituted pyrrolidine derivatives as HIV protease inhibitors. ZA931777B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85059692A 1992-03-13 1992-03-13

Publications (1)

Publication Number Publication Date
ZA931777B true ZA931777B (en) 1993-09-23

Family

ID=25308596

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931777A ZA931777B (en) 1992-03-13 1993-02-12 Substituted pyrrolidine derivatives as HIV protease inhibitors.

Country Status (12)

Country Link
US (1) US5552405A (fr)
EP (1) EP0560269B1 (fr)
JP (1) JP3198191B2 (fr)
AT (1) ATE123275T1 (fr)
AU (1) AU663164B2 (fr)
CA (1) CA2092653C (fr)
DE (1) DE69300169T2 (fr)
HU (1) HU215520B (fr)
NZ (1) NZ247124A (fr)
PL (1) PL173459B1 (fr)
TW (1) TW301651B (fr)
ZA (1) ZA931777B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA93002392A (es) 1992-03-11 2005-02-04 Narhex Ltd Derivados amino de hidrocarburos-oxo e hidroxi-substituidos.
US5888992A (en) 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US6071895A (en) 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
JPH07504654A (ja) 1992-03-11 1995-05-25 ナルヘックス　リミテッド オキソ及びヒドロキシ置換炭化水素のアミン誘導体
DE69300043T2 (de) * 1992-03-13 1995-05-24 Bio Mega Boehringer Ingelheim Substituierte Pipecoline-Säurederivate als HIV-Protease-Hemmer.
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
EP0610745A3 (en) * 1993-02-09 1994-09-28 Miles Inc Novel aminomethylene derivatives as immunosuppressants.
IL110898A0 (en) * 1993-09-10 1994-11-28 Narhex Australia Pty Ltd Polar-substituted hydrocarbons
US5883252A (en) * 1996-01-26 1999-03-16 Vertex Pharmaceuticals Incorporated Aspartyl protease inhibitors
US6803466B1 (en) * 1997-12-08 2004-10-12 The Scripps Research Institute HIV/FIV protease inhibitors having a small P3 residue
EP1039886A4 (fr) * 1997-12-08 2001-05-16 Scripps Research Inst Inhibiteurs de proteases de vih/vif presentant un petit reste p3
US6251906B1 (en) 1998-05-15 2001-06-26 Abbott Laboratories Retroviral protease inhibiting compounds
EP1463807A4 (fr) 2001-12-19 2006-04-12 Bristol Myers Squibb Co Pichia pastoris formate deshydrogenase et ses utilisations
US7662852B2 (en) 2003-05-22 2010-02-16 Lead Chemical Co., Ltd. Compounds and preparations having antiviral effect

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340588C (fr) * 1988-06-13 1999-06-08 Balraj Krishan Handa Derive d'aminoacides
EP0361341A3 (fr) * 1988-09-28 1991-07-03 Miles Inc. Agents thérapeutiques contre le SIDA basés sur des inhibiteurs des protéases du HIV
WO1991008221A1 (fr) * 1989-12-04 1991-06-13 Wisconsin Alumni Research Foundation Inhibiteurs de peptides de protease d'hiv

Also Published As

Publication number Publication date
ATE123275T1 (de) 1995-06-15
CA2092653A1 (fr) 1993-09-14
EP0560269A1 (fr) 1993-09-15
DE69300169D1 (de) 1995-07-06
HU9300729D0 (en) 1993-05-28
CA2092653C (fr) 1998-12-15
AU3516593A (en) 1993-09-16
DE69300169T2 (de) 1995-10-26
TW301651B (fr) 1997-04-01
PL173459B1 (pl) 1998-03-31
HUT70147A (en) 1995-09-28
AU663164B2 (en) 1995-09-28
JPH0625158A (ja) 1994-02-01
EP0560269B1 (fr) 1995-05-31
NZ247124A (en) 1995-09-26
US5552405A (en) 1996-09-03
JP3198191B2 (ja) 2001-08-13
HU215520B (hu) 1999-01-28
PL298038A1 (en) 1993-11-15

Similar Documents

Publication Publication Date Title
CA2131185A1 (fr) Derives substitues de l'acide pipecolinique utilises comme inhibiteurs de la protease du vih
AU697681B2 (en) Retroviral protease inhibiting compounds
ZA931777B (en) Substituted pyrrolidine derivatives as HIV protease inhibitors.
AU694417B2 (en) Cyclic ureas and analogues useful as retroviral protease inhibitiors
DE69321845D1 (en) Hydroxyethylaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
CA2393271A1 (fr) Composes inhibant la protease des retrovirus
AU5161493A (en) Vasopressin antagonist and oxytocin antagonist
FI860878A0 (fi) Aminosyraderivat och foerfarande foer deras framstaellning.
CA2036413A1 (fr) Inhibiteurs de la protease du vih
DK540589A (da) Pyrrolidinderivater